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We have identified the 170 kDa epidermal growth fac-
tor (EGF) receptor in crude membrane fractions iso-
lated from Ehrlich ascites tumor cells by its EGF-de-
pendent phosphorylation with [γ-32Ρ]ΑΤΡ. An apparent
affinity constant for the ligand of 40-50 ΠΜ, based on
the extent of its EGF-dependent phosphorylation, was
calculated. [125I]EGF binds to the 170 kDa receptor and
Scatchard plot analysis shows high affinity and low af-
finity KC,S of 1.7 ΠΜ and 24 ΠΜ, respectively, in whole
cells, and 0.2-0.8ΠΜ and 39-116nM, respectively, in
isolated non-phosphorylated membrane fractions.
We have estimated the presence of 48 χ 103 high affin-
ity and 275 x103 low affinity EGF binding sites per
tumor cell. Phosphoamino acid analysis shows EGF-
dependent phosphorylation of tyrosine and serine re-
sidues. A polyclonal antibody to a human EGF recep-
tor/c-eroB-2 product common cytoplasmic domain
epitope immunoprecipitates a 45 kDa phosphopoly-
peptide from the tumor membrane fractions and from
whole cell lysates. Phosphoamino acid analysis of
the immunoprecipitated 45 kDa phosphopolypeptide
shows the presence of phosphoserine. The immuno-
precipitated 45 kDa polypeptide is able to undergo
EGF-independent phosphorylation, although no sig-
nificant protein kinase activity towards exogenous
substrates is detected.
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The epidermal growth factor (EGF) is involved in prolifera-
tion and differentiation processes in many cell types after
binding to a receptor located in the plasma membrane
(Carpenter, 1987; Maihle and Kung, 1988). Binding of EGF
to its receptor results in a series of sequential signal trans-
duction events leading to mitosis (Hunter and Cooper,
1981; Cohen et a/., 1982; Downward et a/., 1984; Bertics
and Gill, 1985; Moolenaar et a/., 1986; Pandiella et a/.,
1988).
The number of EGF receptors varies in different cells
and in a given cell type under different physiological condi-
tions. Cellular transformation can result from significant
alterations in the levels of expression of this receptor. For
instance, overproduction of the human EGF receptor in
NIH 3T3 fibroblasts results in a ligand-dependent expres-
sion of the transformed phenotype (Di Fiore et a/., 1987).
Also, a large number of EGF receptors has been detected
in some tumor cell types, as it is the case in the human
epidermoid carcinoma A431 cell line (Ullrich ef a/., 1984).
In addition, human hepatoma cell lines exhibiting different
degrees of dedifferentiation have been found to express
variable numbers of high- and low-affinity EGF receptors
(Clementi et a/., 1989). In some tumors, the expression of
truncated analogs of the normal EGF receptor appears to
be involved in cellular transformation (Carpenter, 1987).
These tumor cells are in general able to grow indepen-
dently of mitogenic polypeptide signals.
The presence of EGF receptors has been previously
noticed in Ehrlich ascites tumor cells (Usui et a/., 1985).
However, their properties were not studied in detail. In this
communication we present a comprehensive characteri-
zation of the EGF receptor from this tumor cell line. In addi-
tion, we demonstrate the presence of a membrane-as-
sociated 45 kDa phosphopolypeptide that immunopreci-
pitates using an antibody directed against a human EGF
receptor/c-ert>B-2 product common epitope.
Ehrlich ascites tumor cells exhibit a high rate of [methyl·
3H]thymidine incorporation into DMA in the absence of
EGF (with or without insulin) or fetal calf serum (FCS)
added to the medium, in contrast to non-transformed
Swiss 3T3 mouse fibroblasts which require either EGF
plus insulin or FCS to grow (results not shown). The ab-
sence of EGF-mediated stimulation of the already high
rate of [me#7y/-3H]thymidine incorporation into DMA of
Ehrlich ascites tumor cells raises the possibility that this
tumor cell line harbors an altered EGF receptor or have
an impairment in the EGF-mediated signal transduction
pathway. Thus, with the aim of testing whether EGF in-
duces or not phosphorylation of its pressumptive receptor
we carried out phosphorylation experiments in isolated
membrane fractions, in the absence and presence of EGF.
Figure 1 (left panel) presents an autoradiograph of the
membrane polypeptides from Ehrlich cells that become
phosphorylated using [γ-32Ρ]ΑΤΡ as the phosphate donor.
A170 kDa polypeptide was found to markedly increase its
Brought to you by | CSIC - Unidad Coordinacion Bibliotecas
Authenticated | 161.111.180.191
Download Date | 6/28/13 2:43 PM
294 A. Elexpuruefa/.
EG F
M r I x 10 I
2 0 0 -
1 1 6 -
92-
6 6 -
45 -
12 -
'S 60
2 40
ο
111
cο
'S 20
t ο 12 - 1 0 - 8
log[EGF][M]
- 6
Fig. 1 EGF Induces Phosphorylation of Its Receptor In Isolated
Membranes from Ehrlich Ascites Tumor Cells.
(Left panel) Membranes (100 μ9 of protein) were incubated at
37°C for 1 min in a total volume of 0.1 ml of a medium containing
15 mM 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid, so-
dium salt (Na-Hepes) (pH 7.4), 5mM MgCI2f 0.2 mM [ethylenebis-
(oxyethylenenitrilo)]tetraacetic acid (EGTA), 0.08% (w/v) Triton X-
100, 1 μΜ EGF (when added) and 10 μΜ (1.8 μΟΐ) [γ-32Ρ]ΑΤΡ. The
reaction was arrested with icecold trichloroacetic acid and the
precipitated proteins processed through polyacrylamide linear-
gradient (5-20%, w/v) gel electrophoresis at pH 8.3 in the pres-
ence of 0.1 % (w/v) sodium dodecyl sulfate (SDS). An autoradiog-
raph of the labeled polypeptides is presented. The arrow points to
the 170 kDa EGF receptor. (Right panel) Membranes were phos-
phorylated as indicated above except that the concentration of
EGF was varied. The plot depicts the densitometric intensity of
the 170 kDa band in the autoradiograph versus the concentration
of EGF.
phosphorylation in the presence of EGF (see arrow), by a
factor of 2.5-4 fold. Figure 1 (right panel) depicts the de-
pendence of this phosphorylation on the concentration of
EGF. Above 10~8M EGF an effective increase in the level of
phosphorylation of the 170 kDa polypeptide is observed,
reaching a plateau at 10~7 to 10"6M EGF. From plots similar
to that shown in Figure 1 an apparent affinity constant for
EGF in the range of 40-50 nM was calculated. Transform-
ing growth factor α (TGFa) was also found to stimulate the
phosphorylation of the 170 kDa polypeptide, its apparent
affinity constant for this ligand being in the same range (re-
sults not shown).
The EGF-dependent phosphorylation of the 170 kDa
polypeptide was partially resistant to alkali treatment
(0.5M NaOH, 1 h at 55°C), suggesting that phosphotyro-
sine residues were present in the 170 kDa phosphopoly-
peptide (Cooper et a/., 1983). In agreement with this obser-
vation, phosphoamino acid analysis of the 170 kDa pro-
tein showed an EGF-dependent phosphorylation of
tyrosine residues (Figure 2). Phosphoserine was also de-
tected in basal conditions, and its level increased in the
presence of EGF (Figure 2). An EGF-stimulated phospho-
rylation of tyrosine and serine residues has been shown by
us to take place as well in an isolated EGF receptor prepa-
ration from normal rat liver (San Jose ef a/., 1992).
A phosphorylation time-course analysis of the 170 kDa
polypeptide from Ehrlich ascites tumor cells showed that
maximum levels of phosphorylation were attained in the
presence of EGF 1 min after the addition of [γ-32Ρ]ΑΤΡ.
After this rapid incorporation of phosphate a progressive
dephosphorylation was observed, 50-70% of the label-
ing being lost within the first thirty minutes of reaction (re-
sults not shown). A phosphotyrosyl-directed protein phos-
phatase has been purified from Ehrlich ascites tumor cell
lysates (H rlein et a/., 1982). This enzyme is inhibited by
zinc ion and is distinct from alkaline phosphatase. A simi-
lar phosphotyrosyl-directed protein phosphatase has
been described in A431 cell membrane vesicles. Further-
more, this enzyme has been shown to dephosphorylate
the EGF receptor (H rlein ei a/., 1982). We have tested the
effect of Zn2+ on the phosphorylation levels of the 170 kDa
polypeptide, and found that this cation did not significant-
ly affect its phosphorylation rate, though it efficiently pre-
vented its dephosphorylation in the absence as well as in
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Fig. 2 Phosphoamino Acid Analysis
of the EGF Receptor from Ehrlich As-
cites Tumor Cells.
Ehrlich ascites tumor cell membrane
fractions (100 \IQ of protein) were
phosphorylated as indicated in the
legend of Figure 1, in the absence or
presence of 1μΜ EGF. After elec-
trophoretic separation, the phos-
phorylated 170 kDa band was cut
from the dried gel and processed for
phosphoamino acid analysis (Hunter
and Sefton, 1980).
the presence of EGF (results not shown). These results
suggest that the 170 kDa membrane polypeptide from
Ehrlich ascites tumor cells also becomes dephosphory-
lated by a Zn2*-sensitive phosphoprotein phosphatase.
To ascertain that the 170 kDa membrane polypeptide
from Ehrlich ascites tumor cells was indeed the EGF re-
ceptor we performed [125l]EGF-binding experiments on
purified cell membrane fractions. Figure 3 presents auto-
radiographs obtained after incubation of Ehrlich cell mem-
branes with [125I]EGF in the presence of the cross-linking
agent suberic acid bis(/V-hydroxysuccinimide ester) (DSS)
and in the absence (lane 1) and presence (lane 2) of an
excess of non-radiolabeled EGF. We observed binding
of [125I]EGF to the 170 kDa polypeptide, as well as a chase
effect induced by non-radiolabeled EGF.
Table 1 summarizes the values estimated from Scatch-
ard plot analyses for the high and low affinity constants of
[125I]EGF for its receptor, as well as for the number of re-
ceptors present in whole cells and isolated membrane
preparations. Values obtained in isolated membranes for
the high affinity K^ were in the range of 0.2-0.8 ΠΜ, and for
the low affinity K^ in the range of 39-116nM. Estimated
numbers of 0.2-2.5 χ 1011 and 6-28 χ 1011 receptors per
mg of membrane protein were found for the high- and the
low-affinity receptors, respectively. In whole cells the cal-
culated high affinity Κύ was 1.7 ΠΜ, and the low affinity Κύ
was 24nM. Ca. 48 χ 103 and 275 χ 103 high- and low-affin-
ity receptors, respectively, were also estimated to be pre-
sent per cell. In comparison to other cell lines, the number
of high-affinity EGF receptors found in Ehrlich ascites
tumor cells (48 χ 103) is lower than the number of high af-
finity receptors expressed by the human epidermoid car-
cinoma A431 cells (0.2-0.4 χ 106) (Lokeshwar et a/., 1989).
Also, the total number of receptors (high- and low-affinity)
in Ehrlich ascites tumor cells (0.3 χ 106) is lower than in NIH
3T3 fibroblasts overexpressing the human EGF receptor
(0.3-4 x106) (Di Fiore etal., 1987; Pandiella etal., 1988),
although higher than in human fibroblasts (40-100 χ 103)
or untransfected NIH 3T3 fibroblasts (3 χ 103) (Carpenter
etal., 1975; Di Fiore etal., 1987).
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Fig. 3 [125I]EGF-EGF Receptor Crosslink.
Membranes (200 μg of protein) were incubated at 37°C for 1 h in a
total volume of 100μΙ of a reaction mixture containing 15 mM Na-
Hepes (pH 7.4), 5mM MgCI2> 0.2mM EGTA, 0.08% (w/v) Triton X-
100,1 mM phenylmethanesulfonyl fluoride (PMSF), 10 μΜ leupep-
tin, and 2.1 ΠΜ (0.1 μΟί) [125I]EGF, either in the absence (lanel) or
presence (lane 2) of 1 μΜ non-radiolabeled EGF. Electrophoresis
and autoradiography were performed as indicated in the legend
to Figure 1. The non-specific 66 kDa labeled band observed in the
autoradiograph appears to be a contaminant from the [125I]EGF
commercial preparation and the low molecular mass smeared
band free [125I]EGF.
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Fig. 4 Immunoprecipjtation of a 45 kDa Phosphopolypeptide from Ehrlich AscitesTumor Cells.
Confluent EGFR T17 cells from a 90-mm culture dish (panel A) or isolated Ehrlich ascites tumor cell membranes (100μ9 of protein)
(panel B) were permeabilized with 0.1 % (w/v)Triton X-100, and phosphorylation was assayed with [γ-32Ρ]ΑΤΡ as indicated in the legend of
Figure 1, in the absence (-) or presence (+) of 1 μΜ EG F. Thereafter, the samples were solubilized with 1 % (w/v) Triton X-100 and processed
for electrophoresis and autoradiography before (lanes 1 and 2) and after (lanes 3 and 4) immunoprecipitation (Parker et a/., 1984) with the
antibody mentioned in the text. Arrows point to the 170 kDa EGF receptor from EGFR T17 fibroblasts (panel A), and to the 45 kDa phos-
phopolypeptide from Ehrlich ascites tumor cells (panel B).
Table 1 EGF Binding Parameters of the EGF Receptor from Ehrlich Ascites Tumor Cells.
Ehrlich ascites tumor cells were incubated for 2 h at 37°C in 100 ml of FCS-free RPMI-1640 medium containing 20 mM Na-Hepes (pH 7.4)
and 0.1 % (w/v) bovine serum albumin (BSA). After being washed, the cells (2.1 χ 106) were incubated at 4°C for 4 h in 550 μΐ of the above
medium containing 2 ΠΜ (0.15 μΟ\) [125I]EGF, and different concentrations of non-radiolabeled EGF up to 1 μΜ. The cells were then washed,
and solubilized in 0.5 ml of 0.4M NaOH, and the extracted radioactivity was measured with a γ-ray counter. Alternatively, membrane frac-
tions (200 μg of protein) were incubated at 23°C for 1 h in 200μΐ of 20 mM Na-Hepes (pH 7.4), 0.1 % (w/v) BSA, containing 2nM (0.1 μΟ)
[125I]EGF and different concentrations of non-radiolabeled EGF up to 1 μΜ. The reaction mixtures were diluted thereafter with 2 ml of 20 mM
Na-Hepes (pH 7.4), 0.1 % (w/v) bovine serum albumin (BSA) washed, and fast filtrated through Whatman glass microfibre filters, the as-
sociated radioactivity being measured as above.
Parameter Membranes Whole cells
Kd (high affinity)
Kd (low affinity)
Receptor number (high affinity)
Receptor number (low affinity)
0.2-0.8nM
39-116ΠΜ
0.2-2.5 xlO^
6-28x1011x(mgprot)~1
1.7ΠΜ
24 ΠΜ
48x103xcell"1
275 x103x cell"1
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We performed immunoprecipitation experiments using
an antibody directed to a common epitope shared by the
intracellular domains of the human EGF receptor and the
product of the c-erbB-2 gene (residues 929-947 of the
c-erbB-2 product) (Yamamoto et a/., 1986). Cell lysates
and solubilized membrane fractions from Ehrlich ascites
tumor cells were subjected to immunoprecipitation using
as a control cell lysates of EGFRT17 fibroblasts, a cell line
overexpressing the human EGF receptor (Pandiella et a/.,
1988). Figure 4 presents an autoradiograph of the immu-
noprecipitated material from lysates of EGFR T17 fibro-
blasts (panel A) and from solubilized Ehrlich ascites tumor
cell membranes (panel B) previously phosphorylated with
[γ-32Ρ]ΑΤΡ in the absence (-) or presence (+) of EGF (see
lanes 3 and 4). Phosphorylation patterns of cell lysates
and solubilized membranes before immunoprecipitation
are also presented (lanes 1 and 2).The 170 kDa EGF recep-
tor was clearly detected in immunoprecipitates from
EGFRT17 fibroblasts, although no polypeptide of compar-
able molecular mass was detected in Ehrlich ascites
tumor cells. However, a 45 kDa phosphopolypeptide was
immunoprecipitated from the solubilized Ehrlich ascites
tumor cell membrane fraction. No significant effect was
observed to be exerted by EGF on the phosphorylation
level of this 45 kDa phosphopolypeptide. The phosphory-
lation pattern of the isolated membrane fractions from
Ehrlich tumor cells showed that the 45 kDa phosphopoly-
peptide is a prominent component of the membranes of
these tumor cells. This protein is also immunoprecipitable
from Ehrlich tumor cell lysates (results not shown).
Phosphoamino acid analysis of the 45 kDa phospho-
polypeptide immunoprecipitated from Ehrlich ascites
tumor cells showed the presence of phosphoserine as the
only phosphorylated amino acid (results not shown). This
polypeptide was able to undergo phosphorylation after its
immunoprecipitation, suggesting that autophosphoryla-
tion or, alternatively, phosphorylation by a co-immuno-
precipitated protein kinase was taking place.
Truncated analogs of the normal EGF receptor such as
the v-enbB oncogene product from the avian erythroblas-
tosis virus, or the activated c-erbB oncogene product
from the avian leucosis virus exhibit high sequence
homologies to sections of the normal EGF receptor, but
lacking most of their extracellular ligand binding domains
(Carpenter, 1987). These truncated EGF receptor variants
display hyperactive tyrosine kinase activity. In contrast,
the 45 kDa phosphopolypeptide immunoprecipitated
from Ehrlich ascites tumor cells is not phosphorylated in
tyrosine residues, and protein kinase activity towards
exogenous substrates, such as casein, histone and poly-
L-[Glu:Tyr] (a copolymer of L-glutamic acid and L-tyrosine),
was not detected (results not shown). Furthermore, this
phosphoprotein exhibits a lower molecular mass than the
above mentioned truncated forms of the EGF receptor.
Though the nature of the immunoprecipitated 45 kDa
serine-phosphopolypeptide from Ehrlich ascites tumor
cells is not currently known, several hypotheses can be
raised. One possibility is that this phosphopolypeptide
were a natural EGF receptor variant lacking tyrosine kinase
activity, and its extracellular ligan-binding domain. Alter-
natively, the 45 kDa phosphopolypeptide could be a non-
related protein sharing (a) common epitope(s) with the
EGF receptor. Further work needs to be performed to
elucidate whether this phosphopolypeptide has, if any, a
role in cell proliferation, and if it bears any structural or
functional analogy to the EGF receptor.
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